RecruitingNCT07620470

Spectral Precise Image Study for Brain Tumors

Clinical Study for Exploring Image Quality the Spectral Precise Image in Patients With Diagnosed Intracranial Tumors


Sponsor

Philips Clinical & Medical Affairs Global

Enrollment

120 participants

Start Date

Nov 28, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors. The main question it aims to answer is: The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients with clinical and radiology (MRI/CT) diagnosed brain tumors.
  • Patients who underwent contrast enhanced scans using the Spectral CT 7500.
  • Study participants with age ≥ 18 years old.
  • Study participants that have signed Informed Consent Form (ICF)

Exclusion Criteria3

  • The clinical data or radiological information is considered incomplete after evaluation by the investigator.
  • Study participant that was enrolled in this study in the past
  • Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEThis is an observational data collection study

This is an observational data collection study


Locations(1)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07620470


Related Trials